{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:13:45Z","timestamp":1788614025306,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.seminoncol.2026.152504","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:21:09Z","timestamp":1780327269000},"page":"152504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PSMA PET\/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9639-4486","authenticated-orcid":false,"given":"Fausto","family":"Petrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"Bodrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostina","family":"De Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dottorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Bruschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Riboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Mattiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivano","family":"Vavassori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Seghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seminoncol.2026.152504_bib0001","article-title":"Use of staging in intermediate-risk prostate cancer: a real-world data analysis","author":"Hartwieg","year":"2025","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152504_bib0002","first-page":"24","article-title":"A farewell to arms \u2013 an institutional review of conventional staging for intermediate-risk prostate cancer","volume":"11","author":"Karanjia","year":"2025","journal-title":"J Cancer Allied Spec"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152504_bib0003","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/iju.70003","article-title":"Overuse of imaging in prostate cancer staging","volume":"32","author":"Tohi","year":"2025","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152504_bib0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2967\/jnumed.124.268555","article-title":"Rates of PSMA PET staging and positivity in newly diagnosed prostate cancer in a national health care system","volume":"66","author":"Miller","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.seminoncol.2026.152504_bib0005","article-title":"The role of PSMA PET\/CT in staging patients with intermediate-risk prostate cancer","volume":"136","author":"Bonaddio","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.seminoncol.2026.152504_bib0006","article-title":"Impact of PSMA PET staging on initial treatment in newly diagnosed prostate cancer","author":"Miller","year":"2025","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152504_bib0007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152504_bib0008","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/pros.24884","article-title":"Impact of pelvic lymph node dissection on early oncological outcomes in intermediate-risk prostate cancer patients with node-negative PSMA PET","volume":"85","author":"Esen","year":"2025","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.seminoncol.2026.152504_bib0009","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1007\/s00259-025-07241-y","article-title":"External validation of nomograms including PSMA PET for prediction of lymph node invasion in prostate cancer","volume":"52","author":"Van Bergen","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.seminoncol.2026.152504_bib0010","article-title":"Lymph node dissection based on 18F-PSMA PET\/CT during radical prostatectomy for intermediate and high risk prostate cancer: interim results of a prospective, randomized study","author":"Jia","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152504_bib0011","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/bju.16872","article-title":"Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate-risk prostate cancer","volume":"136","author":"Carll","year":"2025","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152504_bib0012","doi-asserted-by":"crossref","DOI":"10.4081\/aiua.2024.12132","article-title":"Ductal prostate cancer staging: role of PSMA PET\/CT","volume":"96","author":"Pepe","year":"2024","journal-title":"Arch Ital Urol Androl"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152504_bib0013","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.21873\/invivo.13769","article-title":"PSMA PET\/CT accuracy in diagnosing prostate cancer nodes metastases","volume":"38","author":"Pepe","year":"2024","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152504_bib0014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13550-024-01152-z","article-title":"The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer","volume":"14","author":"Donswijk","year":"2024","journal-title":"EJNMMI Res"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:48:10Z","timestamp":1788612490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775426000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0093775426000515"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152504","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSMA PET\/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152504"}}